WOBURN, Mass. CutisPharma, which develops products for prescription compounding, on Wednesday announced a partnership with Rite Aid that will enable the chain to offer compounding services chainwide.

Founded in 1998, CutisPharma Inc. was based on the idea that it could reduce errors in compounding, the process of customizing drugs for particular patients. Its solution: kits with pre-measured ...

Oral Vancomycin Solution Kit Launched CutisPharma announced the launch of FIRST Vancomycin oral solution compounding kits for the treatment of Clostridium difficile (C.diff) infection. CutisPharma ...

WOBURN, Mass., May 15, 2012 /PRNewswire/ -- CutisPharma, Inc. announced the presentation of homogeneity and stability studies for compounded formulations of several ...

WILMINGTON, Mass., March 25, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the commercial availability of FIRST-Atenolol grape-flavored oral solution compounding kit. FIRST-Atenolol provides ...

WILMINGTON, Mass., Jan. 6, 2015 /PRNewswire/ — CutisPharma, a specialty pharmaceutical company focusing on the development and commercialization of value-added kits for the compounding pharmacy market ...

WOBURN, Mass. A company that develops kits for compounding pharmacies has launched the latest addition to its product line. CutisPharma announced Tuesday the introduction of its First – BXN Mouthwash ...

WILMINGTON, Mass., May 21, 2014 /PRNewswire/ -- CutisPharma, Inc. announced its move to a new location at 841 Woburn St. Wilmington, MA. "We are pleased to announce our relocation to a larger facility ...

WOBURN, Mass., Dec. 19, 2012 /PRNewswire/ -- CutisPharma, Inc. today announced that the United States Patent and Trademark Office has issued a patent (US 8,276,757 B2) regarding a method for the ...

WILMINGTON — CutisPharma, which supplies compounding kits to pharmacies, has filed for $20 million in equity financing. The Securities and Exchange filing mentions there are two investors, but does ...